Menu
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Real World Evidence Conference
Session 2: Sizing Up Data Bases and Their Sufficient Fit for Purpose
Session Chair(s)
Nancy A. Dreyer, PhD, MPH, FISPE
- Chief Scientific Officer and Senior Vice President
- IQVIA, United States
Brian D. Bradbury, PhD, MA
- Vice President, Center for Observational Research
- Amgen, United States
The spectrum of data sources for RWE runs the spectrum from pure reliance on existing data to prospective non-interventional studies, randomized trials, and various combinations of linked data. Evaluating quality for a given purpose starts with understanding how the data is collected, where it comes from, and how must-have exposures and outcomes are recorded. Real-world examples showing how diverse types of real-world data outcomes are being validated and used will be presented.
Learning Objective : - Describe the spectrum of evidence that is considered real-world and what circumstances would generally exclude data from being reflective of the “real-world”
- Describe key elements of real-world data that should be considered when existing data, primary data collection, and data linkage
- Discuss at least one example of modern-day use of real-world evidence including why exposure and outcomes were useful as well as any concerns about limitations
Speaker(s)
Speaker
Michael Fried, MD
- Co-Founder & Chief Medical Officer
- TARGET PharmaSolutions, United States

Making Fit-for-Purpose EHR Data Scalable Via a Digital Research Network
Todd Johnson, MD, MBA
- Senior Vice President, Clinical Research and Head, Digital Research Network
- Optum, United States
Primary Data Collection through the FDA MyStudies Mobile App
David Martin, MD, MPH
- Vice President, Pharmacovigilance
- Moderna, United States
Contact us
Registration Questions?
Preconference Short Course
Introduction to Real World Data for Data Geeks
Check out our 2019 Program!